| Orege Société Anonyme | €0.36 | -0.8% | -17.1% | €18.2m | n/a | PS13.1x | E25.3% | n/a | Commercial Services | |
| NFL Biosciences | €1.90 | -3.8% | 15.9% | €18.4m | €4.20 | n/a | n/a | n/a | Pharmaceuticals & Biotech | |
| Valbiotis | €1.19 | -4.2% | -76.1% | €18.7m | €6.35 | PS35.5x | E59.3% | n/a | Pharmaceuticals & Biotech | |
| Passat Société Anonyme | €4.78 | 0.8% | 4.8% | €18.9m | n/a | PE14.4x | n/a | 0% | Retail | |
| Stradim Espace Finances | €5.50 | -6.8% | -16.0% | €18.9m | n/a | PE8.1x | n/a | 3.3% | Real Estate Management and Development | |
| Hamilton Global Opportunities | €43.20 | 0% | -7.7% | €19.3m | n/a | PS70.5x | n/a | n/a | Diversified Financials | |
| Oncodesign Precision Medicine Société anonyme | €1.07 | 4.9% | -50.9% | €19.3m | €2.38 | PS14.4x | E-12.6% | n/a | Pharmaceuticals & Biotech | |